Guardant Health raises 2025 revenue outlook to $970M with Shield partnerships and strong oncology growth (NASDAQ:GH)
Seeking Alpha's Disclaimer: The earnings call insights are compilations of earnings call transcripts and other content available on the Seeking ...
